Alzheimer's & Cognition
Conference Coverage
‘Modest’ benefit for lecanemab in Alzheimer’s disease, but adverse events are common
The Food and Drug Administration is expected to make a decision about possible approval of the drug in January 2023.
From the Journals
Why do women get Alzheimer’s disease more often than men? Study offers clue
Researchers zero in on a gene named USP11, found on the X chromosome.
From the Journals
Children with autism show distinct brain features related to motor impairment
White matter in the brains of children with autism found to be distinct from the white matter in children with developmental coordination disorder...
News
‘A huge deal’: Millions have long COVID, and more are expected
More than a quarter say their condition is severe enough to significantly limit their day-to-day activities.
From the Journals
U.S. dementia rate drops as education, women’s employment rises
Investigators speculated that the decline in dementia prevalence reflects larger socioeconomic changes in the United States.
From the Journals
Nutrition for cognition: A missed opportunity in U.S. seniors?
Those who didn’t use the SNAP program experienced 2 more years of cognitive aging compared with program users.
From the Journals
Traffic-related pollutant tied to increased dementia risk
The clear link between fine particulate matter exposure and increased risk emphasizes the need to address air pollution as a modifiable risk...
From the Journals
Dementia prevalence study reveals inequities
Researchers say inequities likely stem from structural racism and income inequality.
From the Journals
Patients with schizophrenia may be twice as likely to develop dementia
There is increasing evidence that multiple psychiatric symptoms and diagnoses are associated with cognitive decline and dementia.
News
Viagra, Cialis, and Alzheimer’s risk: New data
“The evidence for the use of the drug was never sufficient for clinicians to use it in their patients.”
Opinion
How can I keep from losing my mind?
“To date the actual therapies for dementia have been disappointing.”